Breaking News on Biopharmaceutical Development & Manufacturing

Headlines > April 2017

« Previous month

Samsung Bioepis to take on J&J with FDA approved Remicade biosimilar

24-Apr-2017 - Samsung Bioepis’ Renflexis has become the second biosimilar of rheumatoid arthritis biologic Remicade (infliximab) to be recommended for approval in the US.

UK MHRA announces pre-election quiet period

21-Apr-2017 - Tory Prime Minister Teresa May’s decision to call a snap general election to stymie political opposition of her stewardship of the UK’s withdrawal from the European Union will see the...

A cracking new method: Valneva and Bavarian Nordic’s hen egg alternative

21-Apr-2017 - European biotech companies Valneva and Bavarian Nordic have entered a commercial agreement to develop cell-based vaccines using production methods that are faster and cheaper than methods that use hen’s eggs. ...

BioInvent buys Merck single-use tech to up mAb capacity

21-Apr-2017 - BioInvent International AB has acquired a range of different single-use bioreactors from Germany’s Merck to up monoclonal antibody (mAb) capacity at its plant in Lund, Sweden.

Sartorius Stedim Biotech announces French government-backed R&D project

21-Apr-2017 - Sartorius Stedim Biotech (SSB) has announced a €23m ($24.6m) research and development (R & D) programme with funding from local government bodies La Region Provence-Alpes-Cote d’Azur and la Metropole Aix-Marseille...

Wearable drug delivery tech firm Unilife files for Chapter 11 bankruptcy

20-Apr-2017 - Unilife Corporation has filed for Chapter 11 bankruptcy and confirmed that a key customer for its wearable injectors business has halted a project.


Hey big vendor... Is bioprocessing consolidation good for the end-user?

19-Apr-2017 - Price hikes and lack of innovation, or better buying power and end-to-end services? Experts are split on supplier M&A and its effect on biomanufacturers.

News in brief

Synpromics announces £5.2M British investment in gene therapy tech

19-Apr-2017 - Scottish synthetic biology firm Synpromics has received £5.2M ($6.6M) to enhance its synthetic promoter design technology used in gene therapy development.

1st Stem Cell Community day in Germany

For stem cells 'the process is the product,' says Pluristem

19-Apr-2017 - Manufacturing tweaks have severe effects on the quality and yield of stem cells, says Pluristem which has successfully scaled-up production through a decade of process development evolution.

Cobra to boost gene therapy and CAR-T capacity through £15m investment

18-Apr-2017 - Cobra Biologics has said it will spend £15m ($19m) to increase gene therapy production capacity, citing customer demand and market opportunities.

DHL looks to strengthen presence in South American market

18-Apr-2017 - Deutsche Post DHL Group’s contract logistics business, DHL Supply Chain, has announced its intention to acquire Brazilian transport service provider Polar Transportes. 

Fujifilm invests $130m in CDMO business, ups mammlian bioreactor capacity 70%

18-Apr-2017 - Fujifilm has invested around $130m into facilities in the US and UK weeks after launching its biopharma CDMO business.

UK firms should look to global opportunities to offset Brexit woes, says biotech CEO

18-Apr-2017 - UK life science companies must become global to help offset staffing and funding problems potentially caused by Brexit, says Arecor CEO Sarah Howell.

MilliporeSigma launches M-pleat pattern single-use filters

14-Apr-2017 - MilliporeSigma has launched a range of high area cartridges and single use capsules it says gives biomanufacturers greater efficiency in the filtration step.

Pork firm Smithfield sets up organ supply unit for regenerative meds sector

13-Apr-2017 - Smithfield Foods Inc. has tasked a new bioscience unit with turning byproducts from its pork business into supplies for regenerative meds and drug firms.

GE aiming to be cell therapy production services one-stop-shop

12-Apr-2017 - GE Healthcare has acquired cryopreservation technology firm Asymptote and says more investments are likely as it builds an “end-to-end ecosystem” for cellular therapy production services.

Speed, yield and quality critical for cell line development, says ATUM

12-Apr-2017 - ATUM has launched itself into the mammalian cell line development space after being awarded patents for its Leap-In transposase genome technology.

Automation acquisitions 'capture the future of streamline production,' expert

12-Apr-2017 - There is a growing trend among vendors to integrate automation technologies into their offerings says a bioprocessing expert, as GE Healthcare invests in its partner Zenith.

GE Healthcare teams with CBMG to develop CAR-T and stem cell production tech

11-Apr-2017 - GE Healthcare has agreed to help Cellular Biomedicine Group (CBMG) develop CAR-T and stem cell production technologies to support its aim of making 10,000 cancer cell therapies a year. 

Sanfilippo syndrome gene therapy could be filed in US next year, Abeona

11-Apr-2017 - Abeona Therapeutics says it plans to file its single injection adeno-associated virus (AAV) gene therapy for Sanfilippo syndrome in the US in late 2018.

US biosimilars: Quality trumps manufacturing location, say physicians

11-Apr-2017 - American-made biosimilars hold no advantage in the US market according to patient and physician groups which place emphasis on trusted and reputable manufacturers instead.

Sumitomo Dainippon buys cell therapy processing tech from Hitachi

10-Apr-2017 - Sumitomo Dainippon Pharma Co Ltd has ordered cell culture technologies from Hitachi as part of its effort to develop a treatment for Parkinson’s disease.

Selling cell thawing: Medcision launches early adopter scheme to push tech

07-Apr-2017 - Medcision has started pushing its cell therapy thawing technology through an early adopter scheme designed to encourage adoption by firms with candidates in trials.

1st Stem Cell Community Day - Hamburg, Germany

Stem cells: Single-use bioreactors and microcarriers can overcome scale-up issues, experts

07-Apr-2017 - The only practical way to scale-up volumes of mesenchymal stem cells (MSCs) is by using microcarriers in single-use bioreactors, say scientists from A*STAR and Instituto Superior Técnico.

RESPECT: find out what it means to ADCs, says Eisai subsidiary

07-Apr-2017 - Morphotek Inc has launched an antibody-drug conjugate (ADC) services business incorporating its RESPECT site-specific conjugation technology and eribulin-linker toxin platform.

« Previous month

Key Industry Events


Access all events listing

Our events, Shows & Conferences...